It was reported that left hip revision surgery was performed due to pain and other complications.During the revision the hemi head, modular sleeve and bhr cup were removed.The femoral stem remained implanted.As of today, device return and additional information has been requested for this complaint but has not become available.In the absence of the actual devices, the production records were reviewed for the known devices reportedly involved in this incident.Review of manufacturing records did not reveal any waivers, concessions, manufacturing or material abnormalities that could have contributed to this issue.The available medical documents were reviewed.Review of the provided implantation report did not reveal any inconsistencies related to the surgical technique that could explain the later revision.According to the provided revision report, the patient had increasing pain over the last two years.Intra-operative findings were black and reddish joint fluids, black synovitis and acetabular bone fistulas and blackening consistent with significant metallosis.There was bone loss, destruction and erosion at the acetabulum, lucency with a step-off of off up to 2-3 mm at parts of the cup, some soft tissue attached and loosening.There were further changes described at the trunnion.The cup could be removed easily, but it remains unclear whether the cup was grossly loose.No xrays were provided to assess the implant position.As the device was not available, potential changes consistent with the reported findings could not be identified.Therefore, further assessment of possible contributing factors or a possible root cause cannot be performed.Without return of the actual devices or further information we cannot further investigate or confirm the details supplied in this complaint, and our investigation remains inconclusive.If the products or additional information become available in the future, this case will be reopened.No preventative or corrective action has been initiated as a result of this investigation.
|
Smith + nephew is submitting this report pursuant to the provisions of 21cfr, part 803.This report may be based upon information which smith + nephew has not been able to investigate or verify prior to the required reporting date.This report does not reflect a conclusion by fda, smith + nephew, or its employees, that the report constitutes an admission that the device, smith + nephew or its employees caused or contributed to the potential event described in this report.
|